Home » DNAware Instructions
If your test kit or any of its contents look damaged, or if you need help taking your test, please call +1-855-6RECURO.
Rinse your mouth with water.
Remove one swab from its package.
Open your mouth and place the tip of the swab against the inside of your cheek.
Rub the swab back and forth against the inside of your cheek, about 30 times.
Place the swab you just used into the small clear envelope.
Remove the second swab from its package. Rub the tip against the inside of your other cheek.
Place the second swab into the small clear envelope. Seal the clear envelope.
Place the small, clear envelope containing your 2 swabs into the box. Make sure the silica gel packet is also in the box (but not in the clear envelope).
Place the box in the prepaid package, and ship it to the lab by taking it to a UPS drop off location. Click here to find UPS stores and drop off points near you.
Contact us at +1-855-6RECURO or [email protected] with any questions or if your kit or kit contents look damaged.
Please wait while flipbook is loading. For more related info, FAQs and issues please refer to DearFlip WordPress Flipbook Plugin Help documentation.
Recuro Health is pleased to announce its acquisition of Wellvia, a premier virtual health provider that remotely connects patients to board-certified physicians and behavioral health specialists. The acquisition significantly expands Recuro’s digital health capabilities…
Bob has been leading healthcare and technology businesses for the past 40 years and currently is a Senior Advisor with Frazier Health Partners in their Growth Equity business. He is Executive Chairman of Frazier’s portfolio company Parata Systems. Bob was Chairman and CEO of Vocera, a publicly traded HCIT company, recently sold to Stryker. Before this, he served as CEO of Wound Care Solutions, an operator of outsourced chronic wound care centers. Earlier, he was Chairman and CEO of Neoforma, a publicly traded healthcare technology company, and Executive Vice President and Group President of Cardinal Health, where he was responsible for five subsidiary companies. Bob has also been Division President of four different operating units at Baxter International. Prior to that, he served in various capacities at American Hospital Supply Corporation. Bob also serves on the board of Five9, a cloud-based software company, is Lead Director at Kate Farms, a plant-based nutrition company, and Change Healthcare, an information technology company. He is Chairman of GenapSys, a gene sequencing company and also serves as Chair of the Trustees of Arizona State University.
Phil is a visionary thought leader, award-winning corporate executive and Fortune 500 board level business strategy expert who brings more than 20 years of experience in the financial services, technology, insurance and healthcare industries. Inducted into the prestigious CIO Hall of Fame, he possesses a remarkable cachet of authority, mentorship, and brand intelligence. He is widely respected as an expert on technology innovation, risk management, financial growth and oversight, corporate governance, cybersecurity, and digital transformation, among others. Phil is also a turnaround architect and catalyzer of the highest order, who navigates with integrity and finesse. With a bold goal to help build a world in which the vast power of technology can be positively harnessed, Phil is a go-to visionary and strategist for CEOs, corporations, and billion-dollar startups (or those that aspire to be). A passionate business strategist and board member, Phil is considered an influential voice in the push to evolve how companies create, market and use technologies to transform future growth and profitability, customer engagement and sales, internal and external operations, and ultimately to provide products and services that productively transform our world. Currently supporting numerous innovative companies, as well as private equity and VC firms, at either the board level or as an advisor, through his company, Bay Advisors.
Kris is Co-Founder & CEO of FHCC, an Arch Ventures-funded start-up company (in stealth mode) focused on building the next generation of behavioral health care for seniors. Most recently, Kris served as President of Aegis Living, one of the nation’s leading innovators in providing assisted living, memory care and wellness services to seniors. Prior to jumping into senior health, Kris spent over 16 years at Starbucks Coffee Company where he held multiple senior leadership roles including President of the company’s flagship U.S. Retail division and earlier as President of Starbucks Europe, Middle East & Africa (EMEA). While at Starbucks, Kris developed deep consumer experience leading the development and execution of a number of new product and digital innovations globally, establishing significant new growth partnerships both in the US and Europe and scaling several successful new store concepts and formats. Previously Kris worked for Madrona Venture Group, LLC, a Seattle based venture-capital fund. Early in his career, he was in public service. From 1993 to 2000, Kris held a number of positions in the Clinton White House, including Assistant Press Secretary and Personal Aide to the President. He received his B.A. in Public Administration from the University of Arkansas at Fayetteville.
Tracy is the Founding Partner of 1843 Capital, a venture capital fund focused on early-stage technology companies. Through her work she hopes to change the way we view and experience aging. In 2021, Tracy was named to Forbes Magazine’s Inaugural “50 Over 50” list and in 2019 to Entrepreneur Magazine’s list of “100 Powerful Women.” Notable investments include Beautycounter (Exited: $1B), Tempo Automation (Exited Nasdaq: TMPO), and May Mobility. Formerly, she was a Partner at Baker Capital, a $1Billion growth capital fund and a VP at Robertson Stephens. She is also an Advisory Board member Millennium Technology Venture New Horizons Fund, Adviser UBS Project Entrepreneur, and Board Member Early Stage Montana.
Dr. Paiva is the founder and managing part of OLSF Ventures (OLSF). Through his 20-year venture capital journey, he has been a partner at Sevin Rosen Funds and was a partner at Chisholm Private Capital Partners. Before his venture capital career, Dr. Paiva served as a management consultant for the Life Sciences Industry Group at Pittiglio Rabin Todd & McGrath where he consulted with the top five pharmaceutical companies on product-development and technology-management projects. He also served as an investment banking associate at JP Morgan in New York, providing strategic and investment banking advisory services to Fortune 100 healthcare companies. In addition, Dr. Paiva launched Oklahoma State University’s Center for Health Systems Innovation that has a stated mission to transform rural and Native American health. Dr. Paiva holds a Ph.D. in molecular biology from the University of Oklahoma; an MBA from Dartmouth College’s Amos Tuck School of Business; a master’s degree in microbiology and immunology from the University of Oklahoma Health Science Center; and a BS in microbiology from the University of Oklahoma.
A quintessential entrepreneur, mentor, strategic visionary and company builder, Michael leads the Recuro Health team which includes several leaders from Teladoc, where he served as the founding CEO and Chairman for the first seven years of operations. Under his term, the company grew from a concept to one of the most recognized innovations in healthcare, with nearly two million patient members nationwide. Michael has served as a partner of the Texas Acceleration Group (TAG), an entity formed to assist startup companies and participated as a founder of Palo Duro Records. He is also credited as a founder of Internet Global, a company that delivered the first DSL network and one of the first VOIP networks. Prior to this, he worked as a project engineer at Dallas Power & Light dealing with power plants, distribution, transformer management and integration of renewable energy into the grid. Michael earned a B.S. in engineering from Texas Tech, an M.S. in Physics from the University of Texas at Dallas and a Juris Doctorate from Texas A&M.